Artwork
iconShare
 
Manage episode 431365947 series 2409123
Content provided by The Lancet and The Lancet Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Lancet and The Lancet Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Dr Emmy Boerrigter (Department of Pharmacy, Radboud University Medical Center, Netherlands) discusses her Review on dose selection of novel anticancer drugs: exposing the gap between selected and required doses.

  continue reading

211 episodes